Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-07 · accession 0001209191-23-045045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-08 | 2023-08-07 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.72 | -3,722 | 802.0K | -0.5% | -$6,402 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-07 | S | D | 3,722 | $1.72 | 802,018 | D | — | — |